Annual Report 2025

CONSOLIDATEDSTATEMENT OF PROFIT OR LOSSANDOTHER COMPREHENSIVE INCOME For the year ended 31 December 2025 47 The United Laboratories International Holdings Limited Annual Report 2025 2025 2024 NOTES RMB'000 RMB'000 Revenue 5 13,210,627 13,758,937 Cost of sales (7,696,556) (7,676,546) Gross profit 5,514,071 6,082,391 Other income 6 354,367 356,929 Other gains and losses, net 7 23,371 153,781 Selling and distribution expenses (1,355,051) (1,402,483) Administrative expenses (947,531) (894,112) Research and development expenditures (921,048) (890,757) Other operating expenses (50,202) (36,821) Impairment losses recognised under expected credit loss model, net 9 (20,243) (44,880) Share of results of an associate 21 (51) (192) Finance costs 8 (69,730) (34,958) Profit before taxation 2,527,953 3,288,898 Tax expense 11 (446,871) (631,077) Profit for the year 12 2,081,082 2,657,821 Other comprehensive (expense) income Item that may be reclassified subsequently to profit or loss: Exchange differences arising on translation of foreign operations (1,156) 549 Total comprehensive income for the year 2,079,926 2,658,370